(lp0
S"Big Banks Continue to be Large Stakeholders in Vertex Pharmaceuticals ... Midway Monitor - 8 hours ago Vertex Pharmaceuticals Incorporated 's stock has been a favorite of smart money aka institutions, as of late.Growth Report on Vertex Pharmaceuticals Incorporated  - Aiken AdvocateLatest Stocks: The Vertex Pharmaceuticals Incorporated  PT Set at $75.00 ... - Petro Global News 24"
p1
aS"Vertex's Cystic Fibrosis Strategy In Tune With Concert Buy Seeking Alpha - Mar 7, 2017 At first glance, Vertex Pharmaceuticals  appears to have paid more than enough for Concert Pharmaceuticals'  CTP-656, a once-daily version of its marketed therapy Kalydeco.VERTEX PHARMACEUTICALS INCORPORATED  Files An 8-K Entry into a ... - Market ExclusiveVertex Pharmaceuticals Incorporated  Acquires CTP-656, A Modified ... - Smrt Stck Nws"
p2
aS"Vertex's $160M Deal With Concert Pharmaceuticals Seeking Alpha - Mar 9, 2017 This week began with Vertex Pharmaceuticals Incorporated  announcing a deal to buy the development and commercialization rights of Concert Pharmaceuticals'  cystic fibrosis pipeline candidate, CTP-656 for a cost of&nbsp;..."
p3
aS'Vertex Pharma  Announce Positive Results for Two Ph3 Studies of ... StreetInsider.com - 8 hours ago Vertex Pharmaceuticals Incorporated  today announced results from two Phase 3 studies of the tezacaftor  / ivacaftor combination treatment that showed statistically significant improvements in lung function (percent predicted ...'
p4
aS"Proofpoint, Inc. , Vertex Pharmaceuticals Incorporated  Stock Eyes ... The USA Commerce - Mar 24, 2017 Shares of Proofpoint, Inc.  dropped -6.83% to $73.79. During the trading on 03/23/2017, Company's stock ranged from $76.55 to $72.40.Quarterly EPS Of Vertex Pharmaceuticals Incorporated  At $0.54 - Stock Observer"
p5
aS'Analyst Upgrades  Vertex Pharmaceuticals Incorporated  Stock ... Market Exclusive - Mar 17, 2017 Today, Vertex Pharmaceuticals Incorporated  stock received an upgrade by JMP Securities from Outperform. There are 11 hold ratings, 13 buy ratings on the stock.'
p6
aS'Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex ... Yahoo Finance - Mar 16, 2017 Boston, MA-based, Vertex Pharmaceuticals Incorporated  is a bio-technology company. Over the past one-month period, current quarter estimates moved up from 2 cents per share to 4 cents.'
p7
aS'Vertex Pharmaceuticals Incorporated  Rating Lowered to Hold at Vetr Inc. The Cerbat Gem - Mar 22, 2017 Vertex Pharmaceuticals logo Vertex Pharmaceuticals Incorporated  was downgraded by Vetr from a buy rating to a hold rating in a note issued to investors on Monday.Earnings Clues on Vertex Pharmaceuticals Incorporated , Intuit Inc ... - StockNewsJournalVetr Inc. Lowers Vertex Pharmaceuticals Incorporated  to Hold - BNB Daily '
p8
aS'The Dirty Secret to Trading Vertex Pharmaceuticals Incorporated , VMware ... USA Commerce Daily - 18 hours ago Shares of Vertex Pharmaceuticals Incorporated  are on a recovery track as they have regained 27.06% since bottoming out at $71.46 on Dec. 22, 2016.'
p9
aS"Today's Brokerage Rating: Vertex Pharmaceuticals Incorporated (VRTX ... StockNewsJournal - Mar 13, 2017 Investors who are keeping close eye on the stock of Vertex Pharmaceuticals Incorporated  established that the company was able to keep return on investment at -4.47 in the trailing twelve month while Reuters data showed that industry's&nbsp;...Vertex Pharmaceuticals Incorporated  Upgraded at Vetr Inc. - BNB Daily "
p10
a.